Virtu Financial LLC Citius Pharmaceuticals, Inc. Transaction History

Virtu Financial LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 26, 2024	BUY	$0.65 - $0.86 $33,455 - $44,264	51,470 New	51,470 $39,000
Q2 2023 Jul 27, 2023	BUY	$1.08 - $1.65 $25,753 - $39,345	23,846 New	23,846 $29,000
Q4 2022 Feb 15, 2023	BUY	$0.79 - $1.28 $30,813 - $49,926	39,005 New	39,005 $31,000
Q2 2022 Aug 09, 2022	BUY	$0.88 - $1.87 $71,640 - $152,236	81,410 New	81,410 $75,000
Q3 2021 Nov 12, 2021	SELL	$1.74 - $2.6 $34,300 - $51,253	-19,713 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$1.51 - $4.23 $29,766 - $83,385	19,713 New	19,713 $69,000
Q1 2021 May 19, 2021	SELL	$1.04 - $2.34 $153,569 - $345,531	-147,663 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$0.9 - $1.2 $30,096 - $40,128	33,440 Added 29.28%	147,663 $151,000
Q3 2020 Dec 11, 2020	BUY	$0.83 - $1.51 $18,616 - $33,869	22,430 Added 24.44%	114,223 $119,000
Q2 2020 Aug 07, 2020	BUY	$0.65 - $1.45 $59,665 - $133,099	91,793 New	91,793 $104,000
Q4 2019 Feb 04, 2020	SELL	$0.42 - $1.15 $6,937 - $18,996	-16,519 Closed	0 $0
Q3 2019 Nov 20, 2019	BUY	$0.72 - $1.38 $11,893 - $22,796	16,519 New	16,519 $13,000

23.4M

83.1K

32.1K

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $32.1M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.